Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/DRREDDY stock hub

NSE/DRREDDY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/DRREDDYis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.1T
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/DRREDDY
In the news

Latest news · NSE/DRREDDY

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.8
P25 24.9P50 32.4P75 45.7
Trailing P/E19
P25 24.8P50 35.9P75 56.9
ROE16.1
P25 6.3P50 13.6P75 18.1
ROIC14.4
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/DRREDDY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
243
Groups with data
11
Currency
INR
Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
India
Country code
IN
Employees
27,811
Employees Change
763%
Employees Change Percent
2.82
Enterprise value
INR 1.1T
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
INE089A01023
Last refreshed
2026-05-10
Market cap
INR 1.1T
Price
INR 1,295
Price currency
INR
Rev Per Employee
12,435,043.69x
Sector
Healthcare
Sic
2834
Symbol
nse/DRREDDY
Website
https://www.drreddys.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
5.26%
EV Earnings
18.83x
EV/EBIT
16x
EV/EBITDA
12.36x
EV/FCF
29.06x
EV/Sales
3.08x
FCF yield
3.4%
Forward P/E
22.76x
P/B ratio
2.87x
P/E ratio
19.03x
P/S ratio
3.11x
PE Ratio10 Y
29.15x
PE Ratio3 Y
18.66x
PE Ratio5 Y
24.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
19.22%
EBITDA Margin
24.52%
FCF margin
10.6%
Gross margin
55.18%
Gross Profit
INR 190.8B
Gross Profit Growth
3.35%
Gross Profit Growth Q
-4.58%
Gross Profit Growth3 Y
13.05%
Gross Profit Growth5 Y
13.68%
Net Income
INR 56.6B
Net Income Growth
5.42%
Net Income Growth Q
-14.4%
Net Income Growth Years
4%
Net Income Growth3 Y
15.9%
Net Income Growth5 Y
21.63%
Pretax Margin
21.07%
Profit Margin
16.36%
Profit Per Employee
INR 2M
Profitable Years
16
ROA
7.96
Roa5y
9.82
ROCE
16.42
ROE
16.1
Roe5y
17.03
ROIC
14.38
Roic5y
19.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

28
MetricValue
Cagr10y
9.22%
Cagr15y
10.48%
Cagr1y
12.24%
Cagr20y
11.49%
Cagr3y
10.14%
Cagr5y
5.24%
Div CAGR10
7.18%
Div CAGR3
0%
Div CAGR5
9.86%
EPS Growth
5.58
EPS Growth Q
-14.29
EPS Growth Years
4
EPS Growth3 Y
15.85
EPS Growth5 Y
21.59
FCF Growth
237.35%
FCF Growth3 Y
0.76%
FCF Growth5 Y
14.5%
OCF Growth
75.53%
OCF Growth Q
64.77%
OCF Growth10 Y
4.09%
OCF Growth3 Y
9.31%
OCF Growth5 Y
18.52%
Revenue Growth
11.09x
Revenue Growth Q
4.41x
Revenue Growth Quarters
33x
Revenue Growth Years
8x
Revenue Growth3 Y
13.38x
Revenue Growth5 Y
13.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
INR 0.66
Assets
INR 562.9B
Cash
INR 82.6B
Current Assets
INR 297.5B
Current Liabilities
INR 158.3B
Debt
INR 67.7B
Debt EBITDA
INR 0.79
Debt Equity
INR 0.18
Debt FCF
INR 1.85
Equity
INR 375.8B
Interest Coverage
19.91
Liabilities
INR 187.1B
Long Term Assets
INR 265.4B
Long Term Liabilities
INR 28.8B
Net Cash
INR 14.9B
Net Cash By Market Cap
INR 1.38
Net Cash Growth
68.12%
Net Debt EBITDA
INR -0.18
Net Debt Equity
INR -0.04
Net Debt FCF
INR -0.41
Tangible Book Value
INR 257.6B
Tangible Book Value Per Share
INR 309
WACC
5.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.88
Inventory Turnover
2.06
Net Working Capital
INR 112.8B
Quick ratio
1.18
Working Capital
INR 139.2B
Working Capital Turnover
INR 2.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
0.15%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
INR 8
Dividend Years
25
Dividend Yield
0.63%
Ex Div Date
2025-07-10
Last Dividend
INR 8
Payout Frequency
Annual
Payout Ratio
11.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
141.5%
1Y total return
12.24%
200-day SMA
1,258.2
3Y total return
33.6%
50-day SMA
1,276.8
50-day SMA vs 200-day SMA
50over200
5Y total return
29.07%
All Time High
1,421.5
All Time High Change
-8.93%
All Time High Date
2024-08-21
All Time Low
60.5
All Time Low Change
2,039.67%
All Time Low Date
2005-05-09
ATR
37.33
Beta
0.29
Ch YTD
1.82
High
1,310.2
High52
1,379.7
High52 Date
2025-06-12
High52ch
-6.18%
Low
1,290
Low52
1,138.5
Low52 Date
2025-05-09
Low52ch
13.7%
Ma50ch
1.39%
Price vs 200-day SMA
2.89%
RSI
52.57
RSI Monthly
55.08
RSI Weekly
54.26
Sharpe ratio
0.36x
Sortino ratio
0.83
Total Return
0.78%
Tr YTD
1.82
Tr15y
346.08%
Tr1m
8.23%
Tr1w
0.57%
Tr3m
4.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 66.5B
Operating Income Growth
-4.73
Operating Income Growth Q
-23.4
Operating Income Growth3 Y
10.35
Operating Income Growth5 Y
15.67
Operating margin
19.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
599,497,266%
Net Borrowing
5,647,000,000
Shares Insiders
26.74%
Shares Institutions
63.4%
Shares Qo Q
0%
Shares Yo Y
-0.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

67
MetricValue
Adjusted FCF
INR 36.3B
Average Volume
3,101,282.25x
Bv Per Share
447.2
CAPEX
INR -26.5B
Ch10y
125.8
Ch15y
302.9
Ch1m
8.23
Ch1w
0.57
Ch1y
11.53
Ch20y
670.7
Ch3m
4.29
Ch3y
30.96
Ch5y
25.08
Ch6m
7.39
Change
-1%
Change From Open
-0.69
Close
1,307.6
Days Gap
-0.31
Depreciation Amortization
18,334,000,000
Dollar Volume
1,248,993,147
Earnings Date
2026-05-12
EBIT
INR 66.5B
EBITDA
INR 84.8B
EPS
INR 67.93
F Score
4
FCF
INR 36.7B
FCF EV Yield
3.44x
Financing CF
-6,119,000,000
Fiscal Year End
March
Founded
1,984
Goodwill
12,410,000,000
Graham Number
831.54911
Graham Upside
-35.76
Income Tax
INR 16.7B
Investing CF
-52,327,000,000
Is Primary Listing
0
Last Earnings Date
2026-01-21
Last Report Date
2025-12-31
Last Split Date
2024-10-28
Last Split Type
Forward
Lynch Fair Value
INR 1,472
Lynch Upside
13.68
Ma150
1,255.3
Ma150ch
3.13%
Ma20
1,274.3
Ma20ch
1.59%
Net CF
5,625,000,000
Next Earnings Date
2026-05-12
Open
1,303.5
P FCF Ratio
29.37
P OCF Ratio
17.06
Payment Date
2025-08-23
Position In Range
22.28
Ppne
115,544,000,000
Price Date
2026-05-08
Price EBITDA
INR 12.7
Ptbv Ratio
4.18
Relative Volume
0.31x
Revenue
345,831,000,000x
SBC By Revenue
0.1x
Share Based Comp
345,000,000
Tax By Revenue
4.84x
Tax Rate
22.98%
Tr20y
780.06%
Tr6m
7.39%
Volume
964,846
Z Score
5.49
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

NSE/DRREDDY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.6%
$8.00 annual per share
Payout ratio
+11.8%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+9.9%
0 consecutive years of growth
Total shareholder yield
+0.8%
Next ex-dividend date: 2025-07-10
Performance

NSE/DRREDDY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+12.2%
S&P 500 1Y: n/a
3Y total return
+33.6%
S&P 500 3Y: n/a
5Y total return
+29.1%
S&P 500 5Y: n/a
10Y total return
+141.5%
S&P 500 10Y: n/a
Ownership

Who owns NSE/DRREDDY?

Insider, institutional, and short-interest positioning.

Institutional ownership
+63.4%
Share of float held by funds and institutions
Insider ownership
+26.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.2%
Negative means the company is buying back shares.
Technical

NSE/DRREDDY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.6
Neutral momentum band
Price vs 200-day MA
+2.9%
50/200-day relationship not available
Beta (5Y)
0.29
Less volatile than the market
Sharpe ratio
0.36
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/DRREDDY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/DRREDDY stock rating?

nse/DRREDDY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/DRREDDY analysis?

The full report lives at /stocks/nse/DRREDDY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/DRREDDY?

The latest report frames nse/DRREDDY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/DRREDDY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.